Maria Anitan, Med Communication’s Global Head of Pharmacovigilance and Safety, will be attending the 3-day Pharmacovigilance and Risk Management Strategies Conference, January 27-29 in Washington, DC. With topics such as global regulatory updates from the FDA, EMA, and MHRA; expanding uses of real-world evidence for evidence generation, and hot topics in PV, she is looking forward to connecting with the larger PV community and learning about new developments and updates on regional regulations and guidelines in PV. If you see her at one of the sessions, be sure to introduce yourself!

#pharmacovigilance @DIA #networking